Neoplasma Vol.67, No.1, p.129–136, 2020
|
Title: Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway |
Author: S. B. Liu, L. B. Zhou, H. F. Wang, G. Li, Q. P. Xie, B. Hu |
|
Abstract: The insulin growth factor 2 receptor (IGF2R) belongs to insulin growth factor (IGF) pathway and has been proposed as the tumor suppressor in many cancers. However, its role in bladder cancer is unknown. In the current study, we reported that IGF2R expression was decreased in bladder cancer tissues (pd cell proliferation of bladder cancer cells in vitro and in vivo (pon level of AKT. The findings of this study indicated that IGF2R played a tumor suppressor role in bladder cancer. Downregulation IGF2R may promote tumor growth by activating AKT signaling pathway. IGF2R could be considered as a promising candidate for novel biomarker and therapeutic target for human bladder cancer.
|
|
Keywords: urinary bladder neoplasms, IGF-2 receptor, AKT signaling pathway, cell proliferation |
|
Published online: 29-Jan-2020
|
Year: 2020, Volume: 67, Issue: 1 |
Page From: 129, Page To: 136 |
doi:10.4149/neo_2019_190206N108
|
|
download file |
|
|
|
|